nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—hematologic cancer	0.186	1	CbGaD
Lomitapide—ABCB1—Lenalidomide—hematologic cancer	0.0349	0.0698	CbGbCtD
Lomitapide—CYP3A4—Bexarotene—hematologic cancer	0.0209	0.0418	CbGbCtD
Lomitapide—ABCB1—Daunorubicin—hematologic cancer	0.0205	0.0409	CbGbCtD
Lomitapide—ABCB1—Alitretinoin—hematologic cancer	0.0201	0.0401	CbGbCtD
Lomitapide—CYP3A4—Lomustine—hematologic cancer	0.0195	0.0389	CbGbCtD
Lomitapide—CYP3A4—Busulfan—hematologic cancer	0.0195	0.0389	CbGbCtD
Lomitapide—CYP3A4—Thiotepa—hematologic cancer	0.0173	0.0347	CbGbCtD
Lomitapide—ABCB1—Imatinib—hematologic cancer	0.0157	0.0313	CbGbCtD
Lomitapide—ABCB1—Nilotinib—hematologic cancer	0.0143	0.0285	CbGbCtD
Lomitapide—ABCB1—Vinorelbine—hematologic cancer	0.0141	0.0282	CbGbCtD
Lomitapide—CYP3A4—Methoxsalen—hematologic cancer	0.0135	0.027	CbGbCtD
Lomitapide—CYP3A4—Bortezomib—hematologic cancer	0.0128	0.0256	CbGbCtD
Lomitapide—ABCB1—Dasatinib—hematologic cancer	0.0126	0.0252	CbGbCtD
Lomitapide—ABCB1—Mitoxantrone—hematologic cancer	0.0124	0.0249	CbGbCtD
Lomitapide—CYP3A4—Daunorubicin—hematologic cancer	0.0123	0.0245	CbGbCtD
Lomitapide—ABCB1—Betamethasone—hematologic cancer	0.0111	0.0222	CbGbCtD
Lomitapide—ABCB1—Gemcitabine—hematologic cancer	0.011	0.022	CbGbCtD
Lomitapide—ABCB1—Prednisolone—hematologic cancer	0.0109	0.0219	CbGbCtD
Lomitapide—CYP3A4—Cytarabine—hematologic cancer	0.0108	0.0216	CbGbCtD
Lomitapide—CYP3A4—Teniposide—hematologic cancer	0.0107	0.0213	CbGbCtD
Lomitapide—ABCB1—Prednisone—hematologic cancer	0.0103	0.0207	CbGbCtD
Lomitapide—CYP3A4—Ifosfamide—hematologic cancer	0.00984	0.0197	CbGbCtD
Lomitapide—ABCB1—Irinotecan—hematologic cancer	0.0098	0.0196	CbGbCtD
Lomitapide—CYP3A4—Imatinib—hematologic cancer	0.0094	0.0188	CbGbCtD
Lomitapide—CYP3A4—Ruxolitinib—hematologic cancer	0.00885	0.0177	CbGbCtD
Lomitapide—ABCB1—Vinblastine—hematologic cancer	0.00871	0.0174	CbGbCtD
Lomitapide—ABCB1—Vincristine—hematologic cancer	0.00857	0.0171	CbGbCtD
Lomitapide—CYP3A4—Nilotinib—hematologic cancer	0.00854	0.0171	CbGbCtD
Lomitapide—CYP3A4—Vinorelbine—hematologic cancer	0.00847	0.0169	CbGbCtD
Lomitapide—ABCB1—Cisplatin—hematologic cancer	0.00799	0.016	CbGbCtD
Lomitapide—ABCB1—Etoposide—hematologic cancer	0.00785	0.0157	CbGbCtD
Lomitapide—CYP3A4—Triamcinolone—hematologic cancer	0.00775	0.0155	CbGbCtD
Lomitapide—CYP3A4—Dasatinib—hematologic cancer	0.00755	0.0151	CbGbCtD
Lomitapide—CYP3A4—Mitoxantrone—hematologic cancer	0.00746	0.0149	CbGbCtD
Lomitapide—CYP3A4—Betamethasone—hematologic cancer	0.00665	0.0133	CbGbCtD
Lomitapide—CYP3A4—Prednisolone—hematologic cancer	0.00656	0.0131	CbGbCtD
Lomitapide—ABCB1—Dexamethasone—hematologic cancer	0.00645	0.0129	CbGbCtD
Lomitapide—CYP3A4—Prednisone—hematologic cancer	0.00619	0.0124	CbGbCtD
Lomitapide—CYP3A4—Irinotecan—hematologic cancer	0.00587	0.0117	CbGbCtD
Lomitapide—MTTP—hematopoietic system—hematologic cancer	0.00568	0.354	CbGeAlD
Lomitapide—ABCB1—Doxorubicin—hematologic cancer	0.00535	0.0107	CbGbCtD
Lomitapide—CYP3A4—Vinblastine—hematologic cancer	0.00522	0.0104	CbGbCtD
Lomitapide—ABCB1—Methotrexate—hematologic cancer	0.00519	0.0104	CbGbCtD
Lomitapide—CYP3A4—Vincristine—hematologic cancer	0.00513	0.0103	CbGbCtD
Lomitapide—CYP3A4—Etoposide—hematologic cancer	0.0047	0.0094	CbGbCtD
Lomitapide—CYP3A4—Dexamethasone—hematologic cancer	0.00387	0.00773	CbGbCtD
Lomitapide—MTTP—blood—hematologic cancer	0.00376	0.235	CbGeAlD
Lomitapide—CYP3A4—Doxorubicin—hematologic cancer	0.00321	0.00641	CbGbCtD
Lomitapide—MTTP—testis—hematologic cancer	0.00311	0.194	CbGeAlD
Lomitapide—CYP3A4—hematopoietic system—hematologic cancer	0.000708	0.0442	CbGeAlD
Lomitapide—ABCB1—hematopoietic system—hematologic cancer	0.000501	0.0313	CbGeAlD
Lomitapide—CYP3A4—blood—hematologic cancer	0.000469	0.0293	CbGeAlD
Lomitapide—ABCB1—gonad—hematologic cancer	0.000381	0.0238	CbGeAlD
Lomitapide—ABCB1—blood—hematologic cancer	0.000332	0.0207	CbGeAlD
Lomitapide—ABCB1—bone marrow—hematologic cancer	0.000321	0.02	CbGeAlD
Lomitapide—ABCB1—lung—hematologic cancer	0.000291	0.0182	CbGeAlD
Lomitapide—ABCB1—testis—hematologic cancer	0.000275	0.0171	CbGeAlD
Lomitapide—ABCB1—lymph node—hematologic cancer	0.000199	0.0124	CbGeAlD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—hematologic cancer	6.91e-05	0.00117	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	6.85e-05	0.00116	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYCS—hematologic cancer	6.83e-05	0.00116	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—HSP90AA1—hematologic cancer	6.79e-05	0.00115	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	6.76e-05	0.00114	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD86—hematologic cancer	6.73e-05	0.00114	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—TERT—hematologic cancer	6.71e-05	0.00114	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD40LG—hematologic cancer	6.6e-05	0.00112	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL10—hematologic cancer	6.6e-05	0.00112	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL4—hematologic cancer	6.42e-05	0.00109	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—PDGFRA—hematologic cancer	6.32e-05	0.00107	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-B—hematologic cancer	6.27e-05	0.00106	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—hematologic cancer	6.2e-05	0.00105	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—FASLG—hematologic cancer	6.13e-05	0.00104	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.11e-05	0.00103	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTP1—hematologic cancer	6.02e-05	0.00102	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—FAS—hematologic cancer	5.91e-05	0.001	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL2RA—hematologic cancer	5.88e-05	0.000995	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	5.87e-05	0.000994	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.82e-05	0.000986	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-A—hematologic cancer	5.81e-05	0.000984	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—AQP9—hematologic cancer	5.76e-05	0.000975	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ABCB1—hematologic cancer	5.7e-05	0.000964	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	5.56e-05	0.000941	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTM1—hematologic cancer	5.53e-05	0.000936	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NCOR1—hematologic cancer	5.53e-05	0.000936	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—FOS—hematologic cancer	5.39e-05	0.000912	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—CREB1—hematologic cancer	5.38e-05	0.000911	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	5.36e-05	0.000907	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—CREBBP—hematologic cancer	5.24e-05	0.000887	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	5.24e-05	0.000886	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—hematologic cancer	5.16e-05	0.000873	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD80—hematologic cancer	4.91e-05	0.00083	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—MTHFR—hematologic cancer	4.89e-05	0.000827	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—hematologic cancer	4.79e-05	0.00081	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	4.76e-05	0.000806	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CASP8—hematologic cancer	4.56e-05	0.000772	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	4.55e-05	0.00077	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	4.42e-05	0.000747	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—S100A10—hematologic cancer	4.37e-05	0.000739	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	4.35e-05	0.000737	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.31e-05	0.000729	CbGpPWpGaD
Lomitapide—Sinusitis—Epirubicin—hematologic cancer	4.21e-05	0.000177	CcSEcCtD
Lomitapide—Feeling abnormal—Etoposide—hematologic cancer	4.21e-05	0.000176	CcSEcCtD
Lomitapide—Diarrhoea—Mitoxantrone—hematologic cancer	4.2e-05	0.000176	CcSEcCtD
Lomitapide—Diarrhoea—Irinotecan—hematologic cancer	4.2e-05	0.000176	CcSEcCtD
Lomitapide—Vomiting—Carmustine—hematologic cancer	4.2e-05	0.000176	CcSEcCtD
Lomitapide—Gastrointestinal pain—Etoposide—hematologic cancer	4.18e-05	0.000175	CcSEcCtD
Lomitapide—Infection—Dexamethasone—hematologic cancer	4.18e-05	0.000175	CcSEcCtD
Lomitapide—Infection—Betamethasone—hematologic cancer	4.18e-05	0.000175	CcSEcCtD
Lomitapide—Dizziness—Vincristine—hematologic cancer	4.17e-05	0.000175	CcSEcCtD
Lomitapide—Ill-defined disorder—Prednisone—hematologic cancer	4.16e-05	0.000174	CcSEcCtD
Lomitapide—Vomiting—Alitretinoin—hematologic cancer	4.16e-05	0.000174	CcSEcCtD
Lomitapide—Paraesthesia—Triamcinolone—hematologic cancer	4.16e-05	0.000174	CcSEcCtD
Lomitapide—Infestation NOS—Doxorubicin—hematologic cancer	4.15e-05	0.000174	CcSEcCtD
Lomitapide—Infestation—Doxorubicin—hematologic cancer	4.15e-05	0.000174	CcSEcCtD
Lomitapide—Feeling abnormal—Prednisolone—hematologic cancer	4.15e-05	0.000174	CcSEcCtD
Lomitapide—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	4.15e-05	0.000702	CbGpPWpGaD
Lomitapide—Anaemia—Prednisone—hematologic cancer	4.15e-05	0.000174	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	4.14e-05	0.000701	CbGpPWpGaD
Lomitapide—Headache—Carmustine—hematologic cancer	4.14e-05	0.000173	CcSEcCtD
Lomitapide—Nervous system disorder—Dexamethasone—hematologic cancer	4.12e-05	0.000173	CcSEcCtD
Lomitapide—Nervous system disorder—Betamethasone—hematologic cancer	4.12e-05	0.000173	CcSEcCtD
Lomitapide—Vomiting—Ifosfamide—hematologic cancer	4.11e-05	0.000172	CcSEcCtD
Lomitapide—MTTP—Metabolism—PIK3CG—hematologic cancer	4.11e-05	0.000695	CbGpPWpGaD
Lomitapide—Headache—Alitretinoin—hematologic cancer	4.1e-05	0.000172	CcSEcCtD
Lomitapide—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	4.09e-05	0.000693	CbGpPWpGaD
Lomitapide—Diarrhoea—Gemcitabine—hematologic cancer	4.09e-05	0.000172	CcSEcCtD
Lomitapide—Nausea—Thalidomide—hematologic cancer	4.09e-05	0.000171	CcSEcCtD
Lomitapide—Dyspepsia—Triamcinolone—hematologic cancer	4.08e-05	0.000171	CcSEcCtD
Lomitapide—Hyperhidrosis—Betamethasone—hematologic cancer	4.06e-05	0.00017	CcSEcCtD
Lomitapide—Hyperhidrosis—Dexamethasone—hematologic cancer	4.06e-05	0.00017	CcSEcCtD
Lomitapide—Dizziness—Irinotecan—hematologic cancer	4.06e-05	0.00017	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	4.06e-05	0.000687	CbGpPWpGaD
Lomitapide—Malaise—Prednisone—hematologic cancer	4.05e-05	0.00017	CcSEcCtD
Lomitapide—Body temperature increased—Etoposide—hematologic cancer	4.04e-05	0.000169	CcSEcCtD
Lomitapide—Abdominal pain—Etoposide—hematologic cancer	4.04e-05	0.000169	CcSEcCtD
Lomitapide—Vertigo—Prednisone—hematologic cancer	4.03e-05	0.000169	CcSEcCtD
Lomitapide—Eye disorder—Methotrexate—hematologic cancer	4.02e-05	0.000169	CcSEcCtD
Lomitapide—Vomiting—Vincristine—hematologic cancer	4.01e-05	0.000168	CcSEcCtD
Lomitapide—Asthenia—Cisplatin—hematologic cancer	4e-05	0.000168	CcSEcCtD
Lomitapide—Cardiac disorder—Methotrexate—hematologic cancer	4e-05	0.000167	CcSEcCtD
Lomitapide—Fatigue—Triamcinolone—hematologic cancer	3.99e-05	0.000167	CcSEcCtD
Lomitapide—Urinary tract disorder—Epirubicin—hematologic cancer	3.98e-05	0.000167	CcSEcCtD
Lomitapide—Haematuria—Doxorubicin—hematologic cancer	3.96e-05	0.000166	CcSEcCtD
Lomitapide—Connective tissue disorder—Epirubicin—hematologic cancer	3.96e-05	0.000166	CcSEcCtD
Lomitapide—Urethral disorder—Epirubicin—hematologic cancer	3.95e-05	0.000166	CcSEcCtD
Lomitapide—Headache—Vincristine—hematologic cancer	3.95e-05	0.000166	CcSEcCtD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	3.95e-05	0.000668	CbGpPWpGaD
Lomitapide—Hepatobiliary disease—Doxorubicin—hematologic cancer	3.93e-05	0.000165	CcSEcCtD
Lomitapide—Nausea—Carmustine—hematologic cancer	3.92e-05	0.000164	CcSEcCtD
Lomitapide—Vomiting—Mitoxantrone—hematologic cancer	3.9e-05	0.000164	CcSEcCtD
Lomitapide—Vomiting—Irinotecan—hematologic cancer	3.9e-05	0.000164	CcSEcCtD
Lomitapide—Sinusitis—Doxorubicin—hematologic cancer	3.9e-05	0.000163	CcSEcCtD
Lomitapide—Nausea—Alitretinoin—hematologic cancer	3.89e-05	0.000163	CcSEcCtD
Lomitapide—Mediastinal disorder—Methotrexate—hematologic cancer	3.88e-05	0.000163	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—IFNG—hematologic cancer	3.88e-05	0.000656	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	3.87e-05	0.000655	CbGpPWpGaD
Lomitapide—Chills—Methotrexate—hematologic cancer	3.86e-05	0.000162	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	3.85e-05	0.000651	CbGpPWpGaD
Lomitapide—Headache—Irinotecan—hematologic cancer	3.85e-05	0.000161	CcSEcCtD
Lomitapide—Headache—Mitoxantrone—hematologic cancer	3.85e-05	0.000161	CcSEcCtD
Lomitapide—Nausea—Ifosfamide—hematologic cancer	3.84e-05	0.000161	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.83e-05	0.000161	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.83e-05	0.000161	CcSEcCtD
Lomitapide—Myalgia—Prednisone—hematologic cancer	3.82e-05	0.00016	CcSEcCtD
Lomitapide—Arthralgia—Prednisone—hematologic cancer	3.82e-05	0.00016	CcSEcCtD
Lomitapide—Feeling abnormal—Triamcinolone—hematologic cancer	3.82e-05	0.00016	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	3.82e-05	0.000646	CbGpPWpGaD
Lomitapide—Diarrhoea—Cisplatin—hematologic cancer	3.81e-05	0.00016	CcSEcCtD
Lomitapide—MTTP—Metabolism—CREBBP—hematologic cancer	3.81e-05	0.000644	CbGpPWpGaD
Lomitapide—Vomiting—Gemcitabine—hematologic cancer	3.8e-05	0.000159	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.79e-05	0.000159	CcSEcCtD
Lomitapide—Paraesthesia—Betamethasone—hematologic cancer	3.77e-05	0.000158	CcSEcCtD
Lomitapide—Paraesthesia—Dexamethasone—hematologic cancer	3.77e-05	0.000158	CcSEcCtD
Lomitapide—Discomfort—Prednisone—hematologic cancer	3.77e-05	0.000158	CcSEcCtD
Lomitapide—Eye disorder—Epirubicin—hematologic cancer	3.77e-05	0.000158	CcSEcCtD
Lomitapide—Malnutrition—Methotrexate—hematologic cancer	3.75e-05	0.000157	CcSEcCtD
Lomitapide—Headache—Gemcitabine—hematologic cancer	3.75e-05	0.000157	CcSEcCtD
Lomitapide—Nausea—Vincristine—hematologic cancer	3.75e-05	0.000157	CcSEcCtD
Lomitapide—Cardiac disorder—Epirubicin—hematologic cancer	3.74e-05	0.000157	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	3.72e-05	0.00063	CbGpPWpGaD
Lomitapide—Dyspepsia—Dexamethasone—hematologic cancer	3.7e-05	0.000155	CcSEcCtD
Lomitapide—Dyspepsia—Betamethasone—hematologic cancer	3.7e-05	0.000155	CcSEcCtD
Lomitapide—Urinary tract disorder—Doxorubicin—hematologic cancer	3.68e-05	0.000154	CcSEcCtD
Lomitapide—Asthenia—Etoposide—hematologic cancer	3.66e-05	0.000154	CcSEcCtD
Lomitapide—Connective tissue disorder—Doxorubicin—hematologic cancer	3.66e-05	0.000154	CcSEcCtD
Lomitapide—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	3.66e-05	0.00062	CbGpPWpGaD
Lomitapide—Body temperature increased—Triamcinolone—hematologic cancer	3.66e-05	0.000153	CcSEcCtD
Lomitapide—Urethral disorder—Doxorubicin—hematologic cancer	3.66e-05	0.000153	CcSEcCtD
Lomitapide—Decreased appetite—Dexamethasone—hematologic cancer	3.65e-05	0.000153	CcSEcCtD
Lomitapide—Decreased appetite—Betamethasone—hematologic cancer	3.65e-05	0.000153	CcSEcCtD
Lomitapide—Nausea—Mitoxantrone—hematologic cancer	3.65e-05	0.000153	CcSEcCtD
Lomitapide—Nausea—Irinotecan—hematologic cancer	3.65e-05	0.000153	CcSEcCtD
Lomitapide—Infection—Prednisone—hematologic cancer	3.64e-05	0.000152	CcSEcCtD
Lomitapide—Mediastinal disorder—Epirubicin—hematologic cancer	3.63e-05	0.000152	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.63e-05	0.000152	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.63e-05	0.000152	CcSEcCtD
Lomitapide—Back pain—Methotrexate—hematologic cancer	3.63e-05	0.000152	CcSEcCtD
Lomitapide—Fatigue—Dexamethasone—hematologic cancer	3.62e-05	0.000152	CcSEcCtD
Lomitapide—Fatigue—Betamethasone—hematologic cancer	3.62e-05	0.000152	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	3.62e-05	0.000612	CbGpPWpGaD
Lomitapide—Chills—Epirubicin—hematologic cancer	3.62e-05	0.000152	CcSEcCtD
Lomitapide—MTTP—Metabolism—PIK3CD—hematologic cancer	3.61e-05	0.000611	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	3.6e-05	0.000609	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—MTR—hematologic cancer	3.6e-05	0.000609	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	3.59e-05	0.000608	CbGpPWpGaD
Lomitapide—Nervous system disorder—Prednisone—hematologic cancer	3.59e-05	0.00015	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	3.57e-05	0.000604	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ALB—hematologic cancer	3.57e-05	0.000603	CbGpPWpGaD
Lomitapide—Skin disorder—Prednisone—hematologic cancer	3.56e-05	0.000149	CcSEcCtD
Lomitapide—Nausea—Gemcitabine—hematologic cancer	3.55e-05	0.000149	CcSEcCtD
Lomitapide—Vomiting—Cisplatin—hematologic cancer	3.55e-05	0.000149	CcSEcCtD
Lomitapide—Hyperhidrosis—Prednisone—hematologic cancer	3.54e-05	0.000148	CcSEcCtD
Lomitapide—Malnutrition—Epirubicin—hematologic cancer	3.51e-05	0.000147	CcSEcCtD
Lomitapide—Diarrhoea—Etoposide—hematologic cancer	3.49e-05	0.000146	CcSEcCtD
Lomitapide—Eye disorder—Doxorubicin—hematologic cancer	3.48e-05	0.000146	CcSEcCtD
Lomitapide—Ill-defined disorder—Methotrexate—hematologic cancer	3.48e-05	0.000146	CcSEcCtD
Lomitapide—Anaemia—Methotrexate—hematologic cancer	3.46e-05	0.000145	CcSEcCtD
Lomitapide—Feeling abnormal—Betamethasone—hematologic cancer	3.46e-05	0.000145	CcSEcCtD
Lomitapide—Feeling abnormal—Dexamethasone—hematologic cancer	3.46e-05	0.000145	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	3.46e-05	0.000586	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	3.46e-05	0.000586	CbGpPWpGaD
Lomitapide—Cardiac disorder—Doxorubicin—hematologic cancer	3.46e-05	0.000145	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—IL1B—hematologic cancer	3.46e-05	0.000585	CbGpPWpGaD
Lomitapide—Flatulence—Epirubicin—hematologic cancer	3.46e-05	0.000145	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—CASP3—hematologic cancer	3.45e-05	0.000584	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL2—hematologic cancer	3.45e-05	0.000583	CbGpPWpGaD
Lomitapide—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.44e-05	0.000144	CcSEcCtD
Lomitapide—Gastrointestinal pain—Betamethasone—hematologic cancer	3.44e-05	0.000144	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	3.43e-05	0.000581	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	3.42e-05	0.000579	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3R1—hematologic cancer	3.41e-05	0.000577	CbGpPWpGaD
Lomitapide—Back pain—Epirubicin—hematologic cancer	3.39e-05	0.000142	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	3.38e-05	0.000572	CbGpPWpGaD
Lomitapide—Malaise—Methotrexate—hematologic cancer	3.38e-05	0.000142	CcSEcCtD
Lomitapide—Dizziness—Etoposide—hematologic cancer	3.38e-05	0.000142	CcSEcCtD
Lomitapide—Muscle spasms—Epirubicin—hematologic cancer	3.37e-05	0.000141	CcSEcCtD
Lomitapide—Vertigo—Methotrexate—hematologic cancer	3.37e-05	0.000141	CcSEcCtD
Lomitapide—Mediastinal disorder—Doxorubicin—hematologic cancer	3.36e-05	0.000141	CcSEcCtD
Lomitapide—Chills—Doxorubicin—hematologic cancer	3.35e-05	0.00014	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.34e-05	0.00014	CcSEcCtD
Lomitapide—Dizziness—Prednisolone—hematologic cancer	3.33e-05	0.00014	CcSEcCtD
Lomitapide—Asthenia—Triamcinolone—hematologic cancer	3.32e-05	0.000139	CcSEcCtD
Lomitapide—Body temperature increased—Betamethasone—hematologic cancer	3.32e-05	0.000139	CcSEcCtD
Lomitapide—Abdominal pain—Betamethasone—hematologic cancer	3.32e-05	0.000139	CcSEcCtD
Lomitapide—Body temperature increased—Dexamethasone—hematologic cancer	3.32e-05	0.000139	CcSEcCtD
Lomitapide—Abdominal pain—Dexamethasone—hematologic cancer	3.32e-05	0.000139	CcSEcCtD
Lomitapide—Nausea—Cisplatin—hematologic cancer	3.31e-05	0.000139	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	3.31e-05	0.00056	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	3.31e-05	0.00056	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	3.31e-05	0.00056	CbGpPWpGaD
Lomitapide—Paraesthesia—Prednisone—hematologic cancer	3.29e-05	0.000138	CcSEcCtD
Lomitapide—Ill-defined disorder—Epirubicin—hematologic cancer	3.26e-05	0.000136	CcSEcCtD
Lomitapide—Vomiting—Etoposide—hematologic cancer	3.25e-05	0.000136	CcSEcCtD
Lomitapide—Malnutrition—Doxorubicin—hematologic cancer	3.25e-05	0.000136	CcSEcCtD
Lomitapide—Anaemia—Epirubicin—hematologic cancer	3.24e-05	0.000136	CcSEcCtD
Lomitapide—Dyspepsia—Prednisone—hematologic cancer	3.22e-05	0.000135	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	3.22e-05	0.000545	CbGpPWpGaD
Lomitapide—Headache—Etoposide—hematologic cancer	3.2e-05	0.000134	CcSEcCtD
Lomitapide—Flatulence—Doxorubicin—hematologic cancer	3.2e-05	0.000134	CcSEcCtD
Lomitapide—Myalgia—Methotrexate—hematologic cancer	3.19e-05	0.000134	CcSEcCtD
Lomitapide—Arthralgia—Methotrexate—hematologic cancer	3.19e-05	0.000134	CcSEcCtD
Lomitapide—Chest pain—Methotrexate—hematologic cancer	3.19e-05	0.000134	CcSEcCtD
Lomitapide—Decreased appetite—Prednisone—hematologic cancer	3.18e-05	0.000133	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	3.17e-05	0.000537	CbGpPWpGaD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.17e-05	0.000133	CcSEcCtD
Lomitapide—Malaise—Epirubicin—hematologic cancer	3.16e-05	0.000133	CcSEcCtD
Lomitapide—Fatigue—Prednisone—hematologic cancer	3.16e-05	0.000132	CcSEcCtD
Lomitapide—Headache—Prednisolone—hematologic cancer	3.16e-05	0.000132	CcSEcCtD
Lomitapide—Discomfort—Methotrexate—hematologic cancer	3.15e-05	0.000132	CcSEcCtD
Lomitapide—Vertigo—Epirubicin—hematologic cancer	3.15e-05	0.000132	CcSEcCtD
Lomitapide—MTTP—Metabolism—PIK3CB—hematologic cancer	3.15e-05	0.000533	CbGpPWpGaD
Lomitapide—Back pain—Doxorubicin—hematologic cancer	3.14e-05	0.000132	CcSEcCtD
Lomitapide—Constipation—Prednisone—hematologic cancer	3.13e-05	0.000131	CcSEcCtD
Lomitapide—Muscle spasms—Doxorubicin—hematologic cancer	3.12e-05	0.000131	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	3.12e-05	0.000527	CbGpPWpGaD
Lomitapide—Palpitations—Epirubicin—hematologic cancer	3.1e-05	0.00013	CcSEcCtD
Lomitapide—Dizziness—Triamcinolone—hematologic cancer	3.06e-05	0.000128	CcSEcCtD
Lomitapide—Infection—Methotrexate—hematologic cancer	3.04e-05	0.000127	CcSEcCtD
Lomitapide—Nausea—Etoposide—hematologic cancer	3.03e-05	0.000127	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	3.03e-05	0.000512	CbGpPWpGaD
Lomitapide—Feeling abnormal—Prednisone—hematologic cancer	3.02e-05	0.000126	CcSEcCtD
Lomitapide—Asthenia—Dexamethasone—hematologic cancer	3.02e-05	0.000126	CcSEcCtD
Lomitapide—Asthenia—Betamethasone—hematologic cancer	3.02e-05	0.000126	CcSEcCtD
Lomitapide—Ill-defined disorder—Doxorubicin—hematologic cancer	3.01e-05	0.000126	CcSEcCtD
Lomitapide—Nervous system disorder—Methotrexate—hematologic cancer	3e-05	0.000126	CcSEcCtD
Lomitapide—Anaemia—Doxorubicin—hematologic cancer	3e-05	0.000126	CcSEcCtD
Lomitapide—Gastrointestinal pain—Prednisone—hematologic cancer	2.99e-05	0.000125	CcSEcCtD
Lomitapide—Nausea—Prednisolone—hematologic cancer	2.99e-05	0.000125	CcSEcCtD
Lomitapide—Arthralgia—Epirubicin—hematologic cancer	2.99e-05	0.000125	CcSEcCtD
Lomitapide—Chest pain—Epirubicin—hematologic cancer	2.99e-05	0.000125	CcSEcCtD
Lomitapide—Myalgia—Epirubicin—hematologic cancer	2.99e-05	0.000125	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.98e-05	0.000504	CbGpPWpGaD
Lomitapide—Skin disorder—Methotrexate—hematologic cancer	2.97e-05	0.000125	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.97e-05	0.000124	CcSEcCtD
Lomitapide—Hyperhidrosis—Methotrexate—hematologic cancer	2.96e-05	0.000124	CcSEcCtD
Lomitapide—ABCB1—Metabolism—GMPS—hematologic cancer	2.95e-05	0.000499	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—FTCD—hematologic cancer	2.95e-05	0.000499	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PHYH—hematologic cancer	2.95e-05	0.000499	CbGpPWpGaD
Lomitapide—Discomfort—Epirubicin—hematologic cancer	2.95e-05	0.000124	CcSEcCtD
Lomitapide—Vomiting—Triamcinolone—hematologic cancer	2.95e-05	0.000123	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	2.93e-05	0.000496	CbGpPWpGaD
Lomitapide—Malaise—Doxorubicin—hematologic cancer	2.93e-05	0.000123	CcSEcCtD
Lomitapide—Dry mouth—Epirubicin—hematologic cancer	2.92e-05	0.000122	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	2.92e-05	0.000494	CbGpPWpGaD
Lomitapide—Vertigo—Doxorubicin—hematologic cancer	2.92e-05	0.000122	CcSEcCtD
Lomitapide—Headache—Triamcinolone—hematologic cancer	2.9e-05	0.000122	CcSEcCtD
Lomitapide—Body temperature increased—Prednisone—hematologic cancer	2.89e-05	0.000121	CcSEcCtD
Lomitapide—Abdominal pain—Prednisone—hematologic cancer	2.89e-05	0.000121	CcSEcCtD
Lomitapide—Diarrhoea—Dexamethasone—hematologic cancer	2.88e-05	0.000121	CcSEcCtD
Lomitapide—Diarrhoea—Betamethasone—hematologic cancer	2.88e-05	0.000121	CcSEcCtD
Lomitapide—Palpitations—Doxorubicin—hematologic cancer	2.87e-05	0.00012	CcSEcCtD
Lomitapide—Infection—Epirubicin—hematologic cancer	2.84e-05	0.000119	CcSEcCtD
Lomitapide—Nervous system disorder—Epirubicin—hematologic cancer	2.81e-05	0.000118	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.79e-05	0.000117	CcSEcCtD
Lomitapide—Skin disorder—Epirubicin—hematologic cancer	2.78e-05	0.000117	CcSEcCtD
Lomitapide—Dizziness—Dexamethasone—hematologic cancer	2.78e-05	0.000116	CcSEcCtD
Lomitapide—Dizziness—Betamethasone—hematologic cancer	2.78e-05	0.000116	CcSEcCtD
Lomitapide—Hyperhidrosis—Epirubicin—hematologic cancer	2.77e-05	0.000116	CcSEcCtD
Lomitapide—Arthralgia—Doxorubicin—hematologic cancer	2.76e-05	0.000116	CcSEcCtD
Lomitapide—Myalgia—Doxorubicin—hematologic cancer	2.76e-05	0.000116	CcSEcCtD
Lomitapide—Chest pain—Doxorubicin—hematologic cancer	2.76e-05	0.000116	CcSEcCtD
Lomitapide—Nausea—Triamcinolone—hematologic cancer	2.75e-05	0.000115	CcSEcCtD
Lomitapide—Paraesthesia—Methotrexate—hematologic cancer	2.75e-05	0.000115	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.74e-05	0.000115	CcSEcCtD
Lomitapide—Discomfort—Doxorubicin—hematologic cancer	2.73e-05	0.000114	CcSEcCtD
Lomitapide—MTTP—Metabolism—PTEN—hematologic cancer	2.72e-05	0.00046	CbGpPWpGaD
Lomitapide—Somnolence—Methotrexate—hematologic cancer	2.72e-05	0.000114	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	2.72e-05	0.00046	CbGpPWpGaD
Lomitapide—Dry mouth—Doxorubicin—hematologic cancer	2.7e-05	0.000113	CcSEcCtD
Lomitapide—ABCB1—Metabolism—SMPD3—hematologic cancer	2.7e-05	0.000457	CbGpPWpGaD
Lomitapide—Dyspepsia—Methotrexate—hematologic cancer	2.69e-05	0.000113	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	2.69e-05	0.000455	CbGpPWpGaD
Lomitapide—Vomiting—Betamethasone—hematologic cancer	2.67e-05	0.000112	CcSEcCtD
Lomitapide—Vomiting—Dexamethasone—hematologic cancer	2.67e-05	0.000112	CcSEcCtD
Lomitapide—Decreased appetite—Methotrexate—hematologic cancer	2.66e-05	0.000111	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.64e-05	0.000111	CcSEcCtD
Lomitapide—Fatigue—Methotrexate—hematologic cancer	2.64e-05	0.000111	CcSEcCtD
Lomitapide—Headache—Dexamethasone—hematologic cancer	2.63e-05	0.00011	CcSEcCtD
Lomitapide—Headache—Betamethasone—hematologic cancer	2.63e-05	0.00011	CcSEcCtD
Lomitapide—Infection—Doxorubicin—hematologic cancer	2.63e-05	0.00011	CcSEcCtD
Lomitapide—Asthenia—Prednisone—hematologic cancer	2.63e-05	0.00011	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.62e-05	0.000443	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.61e-05	0.000109	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	2.61e-05	0.000441	CbGpPWpGaD
Lomitapide—Nervous system disorder—Doxorubicin—hematologic cancer	2.6e-05	0.000109	CcSEcCtD
Lomitapide—MTTP—Metabolism—EP300—hematologic cancer	2.59e-05	0.000439	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	2.58e-05	0.000436	CbGpPWpGaD
Lomitapide—Skin disorder—Doxorubicin—hematologic cancer	2.57e-05	0.000108	CcSEcCtD
Lomitapide—Paraesthesia—Epirubicin—hematologic cancer	2.57e-05	0.000108	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	2.57e-05	0.000434	CbGpPWpGaD
Lomitapide—Hyperhidrosis—Doxorubicin—hematologic cancer	2.56e-05	0.000107	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	2.56e-05	0.000433	CbGpPWpGaD
Lomitapide—Somnolence—Epirubicin—hematologic cancer	2.55e-05	0.000107	CcSEcCtD
Lomitapide—Feeling abnormal—Methotrexate—hematologic cancer	2.52e-05	0.000106	CcSEcCtD
Lomitapide—Dyspepsia—Epirubicin—hematologic cancer	2.52e-05	0.000106	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—TNF—hematologic cancer	2.51e-05	0.000425	CbGpPWpGaD
Lomitapide—Diarrhoea—Prednisone—hematologic cancer	2.5e-05	0.000105	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methotrexate—hematologic cancer	2.5e-05	0.000105	CcSEcCtD
Lomitapide—Nausea—Dexamethasone—hematologic cancer	2.5e-05	0.000105	CcSEcCtD
Lomitapide—Nausea—Betamethasone—hematologic cancer	2.5e-05	0.000105	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	2.5e-05	0.000422	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	2.5e-05	0.000422	CbGpPWpGaD
Lomitapide—Decreased appetite—Epirubicin—hematologic cancer	2.49e-05	0.000104	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.47e-05	0.000104	CcSEcCtD
Lomitapide—Fatigue—Epirubicin—hematologic cancer	2.47e-05	0.000103	CcSEcCtD
Lomitapide—Constipation—Epirubicin—hematologic cancer	2.45e-05	0.000103	CcSEcCtD
Lomitapide—Dizziness—Prednisone—hematologic cancer	2.42e-05	0.000101	CcSEcCtD
Lomitapide—Abdominal pain—Methotrexate—hematologic cancer	2.42e-05	0.000101	CcSEcCtD
Lomitapide—Body temperature increased—Methotrexate—hematologic cancer	2.42e-05	0.000101	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.41e-05	0.000101	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.39e-05	0.000405	CbGpPWpGaD
Lomitapide—Paraesthesia—Doxorubicin—hematologic cancer	2.38e-05	9.97e-05	CcSEcCtD
Lomitapide—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.37e-05	0.000402	CbGpPWpGaD
Lomitapide—Feeling abnormal—Epirubicin—hematologic cancer	2.36e-05	9.89e-05	CcSEcCtD
Lomitapide—ABCB1—Metabolism—DCK—hematologic cancer	2.36e-05	0.000399	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ASNS—hematologic cancer	2.36e-05	0.000399	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—B3GAT1—hematologic cancer	2.36e-05	0.000399	CbGpPWpGaD
Lomitapide—Somnolence—Doxorubicin—hematologic cancer	2.36e-05	9.87e-05	CcSEcCtD
Lomitapide—Gastrointestinal pain—Epirubicin—hematologic cancer	2.34e-05	9.81e-05	CcSEcCtD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.34e-05	0.000396	CbGpPWpGaD
Lomitapide—Dyspepsia—Doxorubicin—hematologic cancer	2.33e-05	9.77e-05	CcSEcCtD
Lomitapide—Vomiting—Prednisone—hematologic cancer	2.33e-05	9.75e-05	CcSEcCtD
Lomitapide—Decreased appetite—Doxorubicin—hematologic cancer	2.3e-05	9.65e-05	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	2.3e-05	0.000389	CbGpPWpGaD
Lomitapide—Headache—Prednisone—hematologic cancer	2.29e-05	9.61e-05	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.29e-05	9.59e-05	CcSEcCtD
Lomitapide—Fatigue—Doxorubicin—hematologic cancer	2.28e-05	9.57e-05	CcSEcCtD
Lomitapide—Constipation—Doxorubicin—hematologic cancer	2.27e-05	9.49e-05	CcSEcCtD
Lomitapide—Abdominal pain—Epirubicin—hematologic cancer	2.26e-05	9.49e-05	CcSEcCtD
Lomitapide—Body temperature increased—Epirubicin—hematologic cancer	2.26e-05	9.49e-05	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.26e-05	0.000382	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	2.25e-05	0.000381	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	2.24e-05	0.000379	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HDC—hematologic cancer	2.24e-05	0.000378	CbGpPWpGaD
Lomitapide—Asthenia—Methotrexate—hematologic cancer	2.2e-05	9.2e-05	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.19e-05	0.000371	CbGpPWpGaD
Lomitapide—Feeling abnormal—Doxorubicin—hematologic cancer	2.18e-05	9.15e-05	CcSEcCtD
Lomitapide—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.18e-05	0.000369	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.18e-05	0.000368	CbGpPWpGaD
Lomitapide—Nausea—Prednisone—hematologic cancer	2.17e-05	9.11e-05	CcSEcCtD
Lomitapide—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.17e-05	9.08e-05	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	2.16e-05	0.000365	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.15e-05	0.000364	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	2.14e-05	0.000362	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.13e-05	0.000361	CbGpPWpGaD
Lomitapide—Body temperature increased—Doxorubicin—hematologic cancer	2.09e-05	8.78e-05	CcSEcCtD
Lomitapide—Abdominal pain—Doxorubicin—hematologic cancer	2.09e-05	8.78e-05	CcSEcCtD
Lomitapide—Diarrhoea—Methotrexate—hematologic cancer	2.09e-05	8.77e-05	CcSEcCtD
Lomitapide—Asthenia—Epirubicin—hematologic cancer	2.05e-05	8.61e-05	CcSEcCtD
Lomitapide—ABCB1—Metabolism—CDA—hematologic cancer	2.05e-05	0.000346	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	2.03e-05	0.000344	CbGpPWpGaD
Lomitapide—Dizziness—Methotrexate—hematologic cancer	2.02e-05	8.48e-05	CcSEcCtD
Lomitapide—ABCB1—Metabolism—PC—hematologic cancer	1.97e-05	0.000333	CbGpPWpGaD
Lomitapide—Diarrhoea—Epirubicin—hematologic cancer	1.96e-05	8.21e-05	CcSEcCtD
Lomitapide—Vomiting—Methotrexate—hematologic cancer	1.95e-05	8.15e-05	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.93e-05	0.000327	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CA—hematologic cancer	1.92e-05	0.000325	CbGpPWpGaD
Lomitapide—Headache—Methotrexate—hematologic cancer	1.92e-05	8.03e-05	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.9e-05	0.000322	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GBA—hematologic cancer	1.9e-05	0.000322	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.9e-05	0.000322	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.9e-05	0.000322	CbGpPWpGaD
Lomitapide—Asthenia—Doxorubicin—hematologic cancer	1.9e-05	7.97e-05	CcSEcCtD
Lomitapide—Dizziness—Epirubicin—hematologic cancer	1.89e-05	7.93e-05	CcSEcCtD
Lomitapide—Vomiting—Epirubicin—hematologic cancer	1.82e-05	7.63e-05	CcSEcCtD
Lomitapide—CYP3A4—Metabolism—FTCD—hematologic cancer	1.82e-05	0.000308	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GMPS—hematologic cancer	1.82e-05	0.000308	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PHYH—hematologic cancer	1.82e-05	0.000308	CbGpPWpGaD
Lomitapide—Nausea—Methotrexate—hematologic cancer	1.82e-05	7.62e-05	CcSEcCtD
Lomitapide—Diarrhoea—Doxorubicin—hematologic cancer	1.81e-05	7.6e-05	CcSEcCtD
Lomitapide—Headache—Epirubicin—hematologic cancer	1.79e-05	7.52e-05	CcSEcCtD
Lomitapide—Dizziness—Doxorubicin—hematologic cancer	1.75e-05	7.34e-05	CcSEcCtD
Lomitapide—ABCB1—Metabolism—MTAP—hematologic cancer	1.74e-05	0.000294	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.74e-05	0.000294	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.7e-05	0.000288	CbGpPWpGaD
Lomitapide—Nausea—Epirubicin—hematologic cancer	1.7e-05	7.13e-05	CcSEcCtD
Lomitapide—Vomiting—Doxorubicin—hematologic cancer	1.68e-05	7.06e-05	CcSEcCtD
Lomitapide—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.66e-05	0.000281	CbGpPWpGaD
Lomitapide—Headache—Doxorubicin—hematologic cancer	1.66e-05	6.96e-05	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.66e-05	0.000281	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.65e-05	0.00028	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.6e-05	0.000271	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.6e-05	0.000271	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.6e-05	0.00027	CbGpPWpGaD
Lomitapide—Nausea—Doxorubicin—hematologic cancer	1.57e-05	6.59e-05	CcSEcCtD
Lomitapide—MTTP—Metabolism—AKT1—hematologic cancer	1.57e-05	0.000265	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.57e-05	0.000265	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—FHL2—hematologic cancer	1.55e-05	0.000262	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.53e-05	0.000258	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AGRN—hematologic cancer	1.52e-05	0.000257	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.48e-05	0.000251	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.45e-05	0.000246	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—DCK—hematologic cancer	1.45e-05	0.000246	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ASNS—hematologic cancer	1.45e-05	0.000246	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.45e-05	0.000245	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—IDH2—hematologic cancer	1.44e-05	0.000244	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HMMR—hematologic cancer	1.44e-05	0.000244	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HDC—hematologic cancer	1.38e-05	0.000233	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.37e-05	0.000231	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ARNTL—hematologic cancer	1.36e-05	0.000229	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.33e-05	0.000225	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.33e-05	0.000224	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CA9—hematologic cancer	1.32e-05	0.000223	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ACP5—hematologic cancer	1.32e-05	0.000223	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NCOR2—hematologic cancer	1.3e-05	0.00022	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CDA—hematologic cancer	1.26e-05	0.000213	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—IDH1—hematologic cancer	1.24e-05	0.00021	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.24e-05	0.00021	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.23e-05	0.000208	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTO1—hematologic cancer	1.23e-05	0.000207	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—TXN—hematologic cancer	1.23e-05	0.000207	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ABCC3—hematologic cancer	1.23e-05	0.000207	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PC—hematologic cancer	1.21e-05	0.000205	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SPHK1—hematologic cancer	1.2e-05	0.000203	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.17e-05	0.000198	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GBA—hematologic cancer	1.17e-05	0.000198	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—UGT1A1—hematologic cancer	1.15e-05	0.000195	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.13e-05	0.000191	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC22A1—hematologic cancer	1.12e-05	0.00019	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CRABP1—hematologic cancer	1.12e-05	0.00019	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALOX5—hematologic cancer	1.09e-05	0.000185	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.09e-05	0.000185	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MTAP—hematologic cancer	1.07e-05	0.000181	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NUP98—hematologic cancer	1.06e-05	0.000179	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ADCY7—hematologic cancer	1.03e-05	0.000174	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NCOA3—hematologic cancer	1.03e-05	0.000174	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NUP214—hematologic cancer	1.02e-05	0.000173	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—MTR—hematologic cancer	9.99e-06	0.000169	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ABCG2—hematologic cancer	9.99e-06	0.000169	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ENO2—hematologic cancer	9.8e-06	0.000166	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—FHL2—hematologic cancer	9.55e-06	0.000162	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTT1—hematologic cancer	9.5e-06	0.000161	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AGRN—hematologic cancer	9.37e-06	0.000159	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SDC1—hematologic cancer	9.29e-06	0.000157	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	9.22e-06	0.000156	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.9e-06	0.000151	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—IDH2—hematologic cancer	8.88e-06	0.00015	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HMMR—hematologic cancer	8.88e-06	0.00015	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ARNTL—hematologic cancer	8.35e-06	0.000141	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	8.33e-06	0.000141	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CA9—hematologic cancer	8.12e-06	0.000137	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ACP5—hematologic cancer	8.12e-06	0.000137	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NCOR2—hematologic cancer	8.02e-06	0.000136	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NQO1—hematologic cancer	7.9e-06	0.000134	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CD44—hematologic cancer	7.9e-06	0.000134	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—IDH1—hematologic cancer	7.64e-06	0.000129	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.55e-06	0.000128	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.55e-06	0.000128	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—TXN—hematologic cancer	7.55e-06	0.000128	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYCS—hematologic cancer	7.47e-06	0.000126	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HSP90AA1—hematologic cancer	7.43e-06	0.000126	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.39e-06	0.000125	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	7.1e-06	0.00012	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.91e-06	0.000117	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.91e-06	0.000117	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.73e-06	0.000114	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTP1—hematologic cancer	6.59e-06	0.000111	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NUP98—hematologic cancer	6.52e-06	0.00011	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.33e-06	0.000107	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.33e-06	0.000107	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NUP214—hematologic cancer	6.28e-06	0.000106	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.16e-06	0.000104	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MTR—hematologic cancer	6.16e-06	0.000104	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTM1—hematologic cancer	6.05e-06	0.000102	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NCOR1—hematologic cancer	6.05e-06	0.000102	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ENO2—hematologic cancer	6.04e-06	0.000102	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.85e-06	9.91e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SDC1—hematologic cancer	5.72e-06	9.68e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—MTHFR—hematologic cancer	5.35e-06	9.05e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CD44—hematologic cancer	4.87e-06	8.23e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NQO1—hematologic cancer	4.87e-06	8.23e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYCS—hematologic cancer	4.6e-06	7.79e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.57e-06	7.74e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CG—hematologic cancer	4.49e-06	7.61e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CREBBP—hematologic cancer	4.17e-06	7.05e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.06e-06	6.87e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.95e-06	6.69e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALB—hematologic cancer	3.9e-06	6.6e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.84e-06	6.5e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.73e-06	6.31e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.73e-06	6.31e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.73e-06	6.31e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.44e-06	5.83e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.3e-06	5.58e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTEN—hematologic cancer	2.98e-06	5.04e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—EP300—hematologic cancer	2.84e-06	4.8e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.77e-06	4.69e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.57e-06	4.34e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.43e-06	4.12e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALB—hematologic cancer	2.4e-06	4.07e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.3e-06	3.89e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.12e-06	3.59e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.1e-06	3.55e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTEN—hematologic cancer	1.83e-06	3.1e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—EP300—hematologic cancer	1.75e-06	2.96e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AKT1—hematologic cancer	1.72e-06	2.9e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.29e-06	2.19e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AKT1—hematologic cancer	1.06e-06	1.79e-05	CbGpPWpGaD
